We are writing to apprise you of plans for the fall Bridge Project request for applications (RFA). Just as in your own groups, some of the Bridge Project’s processes and timelines have been disrupted by the coronavirus. However, as much as we are able at this moment, we want to let you know what to expect.
We hope to be able to release a formal RFA in early November, with applications to be due in early December and review sessions to be held in early 2021. (Note that there will be no letter of intent required for this year’s applications.) This condensed timeline should allow funding periods to begin in the spring and run on a similar schedule as previous years. Between now and November, we encourage you all to begin thinking in an informal way about ideas for research projects and developing teams.
Please email firstname.lastname@example.org with any questions.
ABOUT THE BRIDGE PROJECT
The Bridge Project is a collaboration between the Koch Institute and the Dana-Farber/Harvard Cancer Center (DF/HCC), designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care.
To encourage the formation of cross-disciplinary teams, we regularly hold informational sessions, workshops, and symposia based on complex translational problems in cancer. Check below for information about upcoming Bridge Project opportunities and events, or click the listings to the left to view videos from previous events.
Bridge Project funding is currently being applied to any aspect of translational cancer research — with preference given to work related to issues of high unmet medical need, for which advances in and/or technologies for early detection, more accurate diagnosis, monitoring, treatment, and prevention are required.